Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma

BACKGROUND: Glioblastoma multiforme (GBM) is one of the most aggressive human tumors, and the establishment of an effective therapeutic reagent is a pressing priority. Recently, it has been shown that the tumor tissue consists of heterogeneous components and that a highly aggressive population shoul...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kohsaka, Shinji, Hinohara, Kunihiko, Wang, Lei, Nishimura, Tatsunori, Urushido, Masana, Yachi, Kazuhiro, Tsuda, Masumi, Tanino, Mishie, Kimura, Taichi, Nishihara, Hiroshi, Gotoh, Noriko, Tanaka, Shinya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Basic and Translational Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057138/
https://ncbi.nlm.nih.gov/pubmed/24470554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not315
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak